STOCK TITAN

Fresenius Medical Care AG - $FMS STOCK NEWS

Welcome to our dedicated page for Fresenius Medical Care news (Ticker: $FMS), a resource for investors and traders seeking the latest updates and insights on Fresenius Medical Care stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Fresenius Medical Care's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Fresenius Medical Care's position in the market.

Rhea-AI Summary
Fresenius Medical Care (FME) announces divestments as part of its Portfolio Optimization Program, with a focus on improving leverage ratio and simplifying the company's portfolio. The company has already closed transactions in Argentina and the US, with additional divestments in progress. The divested assets include 127 facilities, more than 4,500 employees, and more than 10,000 dialysis patients, representing a total proforma revenue of around EUR 600 million in 2022. The company expects net proceeds of around EUR 500 million from the divestments, with the remainder to occur in 2024. However, the divestments are estimated to negatively impact 2025 revenue by EUR 1.5 billion but positively impact 2025 margin.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.44%
Tags
none
-
Rhea-AI Summary
Fresenius Medical Care (FMS) completes change of legal form to Aktiengesellschaft (AG), strengthening corporate governance structure, free float shareholders, and flexibility. The Management Board remains unchanged, while the new Supervisory Board takes office immediately. The business model and strategic plan continue to drive improved operating performance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.2%
Tags
none
-
Rhea-AI Summary
Fresenius Medical Care (FME, FMS) resolves legal dispute with the U.S. government, expecting a net positive impact on operating income of approx. EUR 175 million in Q4 2023. The company raises its earnings outlook, anticipating a 12 to 14 percent growth in operating income in fiscal year 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.46%
Tags
Rhea-AI Summary
Fresenius Medical Care reports solid organic growth in Care Enablement and Care Delivery, with stable same market treatment growth in the U.S. The company has successfully executed its turnaround plan, driving productivity improvements and pricing in Care Enablement. The FME25 transformation savings are on track. FY 2023 earnings outlook has been raised.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.29%
Tags
-
Rhea-AI Summary
Fresenius Medical Care appoints Craig Cordola as new Management Board member for the Care Delivery segment. Cordola will start on January 1, 2024, as CEO of Care Delivery. He will succeed William Valle, who is retiring at the end of 2023. Cordola brings experience in healthcare systems and organizations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.48%
Tags
management
-
Rhea-AI Summary
Fresenius Medical Care announces the presentation of over 60 research abstracts at the American Society of Nephrology's Kidney Week 2023. The presentations cover topics such as advances in machine learning and artificial intelligence in kidney care, home dialysis, and hemodiafiltration and hemodialysis therapies. The company's global scope and scale are highlighted in creating data-driven insights for improving patient care and outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.48%
Tags
none
Rhea-AI Summary
Fresenius Medical Care achieves key AI milestone with first phase completion of largest global dialysis clinical dataset
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.6%
Tags
-
Rhea-AI Summary
Capital Square announces the sale of a medical building in Winchester, Virginia with a 149.09% total return for DST investors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.55%
Tags
none
-
Rhea-AI Summary
Capital Square announces sale of medical building in Kinston, NC
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-17.57%
Tags
none
Rhea-AI Summary
Fresenius Medical Care announces FDA clearance of VersiHD with GuideMe Software
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.6%
Tags
Fresenius Medical Care AG

NYSE:FMS

FMS Rankings

FMS Stock Data

12.24B
198.83M
7.3%
0.19%
Kidney Dialysis Centers
Health Care and Social Assistance
Link
United States of America
Bad Homburg Vor Der Hohe

About FMS

Fresenius Medical Care AG & Co. KGaA is an American German healthcare company which provides kidney dialysis services.